EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer

被引：0
|
作者：
Zhenhuan Xiao
Yun Liu
Qun Li
Qinyuan Liu
Yong Liu
Yan Luo
Songzhi Wei
机构：
[1] The Shenzhen Hospital of Southern Medical University,Department of General Surgery
[2] The First Affiliated Hospital of Nanchang University,Department of Pediatrics
[3] The Shenzhen Hospital of Southern Medical University,Health Management Center
[4] The People’s Hospital of Leping City,Department of Oncology
[5] The Third Affiliated Hospital of Nanchang University,Department of Oncology
[6] The Third Hospital of Nanchang,Department of Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 88卷
关键词：
Colorectal cancer; Chemoresistance; Chemosensitivity; Oxaliplatin; miR-1915-3p;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1021 / 1031
页数：10
相关论文
共 50 条
  • [21] MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells
    Liang, Hui
    Xu, Yisong
    Zhang, Qiang
    Yang, Yu
    Mou, Yueyang
    Gao, Yingchun
    Chen, Rui
    Chen, Chao
    Dai, Penggao
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 725 - 736
  • [22] miR-1915-3p和Bcl-2在结肠癌组织中的表达及其临床意义
    姚晓慧
    中国当代医药, 2022, 29 (09) : 70 - 73
  • [23] Altered miR-17-5p expression pattern in response to chemotherapeutic drugs for metastatic colorectal cancer
    Despotovic, J.
    Urosevic, J.
    Gomis, R. R.
    Nikolic, A.
    FEBS OPEN BIO, 2018, 8 : 295 - 296
  • [24] miR-15a-5p Regulates Oxaliplatin Resistance in Colorectal Cancer through the Wnt/β-catenin Pathway
    Yanjie HUANG
    Tong XU
    Luwen WEN
    Qi FENG
    Jining ZHENG
    Medicinal Plant, 2022, (03) : 9 - 13
  • [25] Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells
    Sundaramoorthy, Pasupathi
    Ramasamy, Thiruganesh
    Mishra, Siddhartha Kumar
    Jeong, Keun-Yeong
    Yong, Chul Soon
    Kim, Jong Oh
    Kim, Hwan Mook
    ACTA BIOMATERIALIA, 2016, 42 : 220 - 231
  • [26] Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts
    Nukatsuka, Mamoru
    Nakagawa, Fumio
    Takechi, Teiji
    ANTICANCER RESEARCH, 2015, 35 (09) : 4605 - 4615
  • [27] LNCRNA XIST REGULATED CHEMOTHERAPEUTIC SENSITIVITY OF MIR-125B-2-3P BY TARGETING WEE1 IN COLORECTAL CANCER
    Zeng, Zhao-lei
    Lu, Jia-huan
    Wang, Yun
    Wang, Ying
    Chen, Zhan-hong
    Yang, Dong-dong
    GUT, 2019, 68 : A25 - A25
  • [28] Serum exosomal miR-377-3p and miR-381-3p as diagnostic biomarkers in colorectal cancer
    Wang, Li
    Song, Xingguo
    Yu, Miao
    Niu, Limin
    Zhao, Yajing
    Tang, Youyong
    Zheng, Baibing
    Song, Xianrang
    Xie, Li
    FUTURE ONCOLOGY, 2022, 18 (07) : 793 - 805
  • [29] miR-485-3p and miR-4728-5p as Tumor Suppressors in Pathogenesis of Colorectal Cancer
    Gurer, T.
    Aytekin, A.
    Caki, E.
    Gezici, S.
    MOLECULAR BIOLOGY, 2022, 56 (03) : 474 - 488
  • [30] miR-485-3p and miR-4728-5p as Tumor Suppressors in Pathogenesis of Colorectal Cancer
    T. Gurer
    A. Aytekin
    E. Caki
    S. Gezici
    Molecular Biology, 2022, 56 : 474 - 488
12345